ArticleOpen forum infectious diseases2022

Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.

Amy C Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.